AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2022

Apr 22, 2022

32853_dirs_2022-04-21_ef2067c8-58f3-41fb-922a-ad5cf19faf21.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2022-04-20

Reporting Person: Davis Jeremy Steven (SVP Chief Commercial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-04-20	Restricted Stock Units	$	A	250000	Acquired		Common Stock (250000.0)	Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.

F2: Restricted Stock Units vest as to 1/4th of the underlying shares on May 20, 2023, and as to an additional 1/16th of the total number of shares each quarter thereafter.